Most studies assessing hCG efficacy have been performed in males with congenital/idiopathic hypogonadotropic hypogonadism.397, 398 While the literature regarding hCG use in adult males with symptomatic testosterone deficiency is less robust, several important reports are worth discussing. It is approved in some countries for treatment of testosterone deficiency but is not currently approved in the US. Methyltestosterone is an oral androgen modified at the 17-alpha position resulting in decreased first pass hepatic clearance and is approved in the US for treatment of testosterone deficiency. A larger study that examined the contraceptive efficacy of testosterone-induced azoospermia in men was conducted by the WHO Task Force on Methods for the Regulation of Male Fertility.385 A total of 271 healthy, fertile men across 7 countries were given 200 mg IM testosterone enanthate every week for 12 months. It is possible that exercise programs coupled with diet may have a greater likelihood of success in achieving increases in total testosterone over calorie-restricted diets alone. However, most of the studies had issues with cohort selection and choice 20,21. As there was no effect of luteinizing hormone, the authors concluded that ‘primary hypogonadism’ was not a risk ‘factor’ for T2DM but that low TT should be considered a risk ‘marker’ for T2DM. A major reason for this diminished relationship in some studies was adjustment for central fat by waist circumference. Furthermore, low FT and sex hormone binding globulin (SHBG) have been shown to predict the onset of diabetes in men in up to 10 years of follow-up (odds ratio OR, 1.58 for a decrease of 4 ng/dL FT and OR, 1.89 for a decrease of 16 nmol/L SHBG) . Recent re-classification of HG by the Endocrine Society refers to T2DM related HG as ‘functional’ and some endocrine guidelines suggest that only ‘classical’ HG be treated, despite no published studies demonstrating that this group responds better. The 2018 Endocrine Society guidelines, in contrast, continues to advise against any form of testosterone screening. Although the link between low testosterone levels and IR is not solely a consequence of adiposity, the study by Grossmann et al. suggests that a substantial component is mediated through its association with body fat, in particular abdominal visceral adipose tissue. In studies from diabetic clinics, total, bioavailable, and free testosterone levels were low in men with T2DM 16,17. The aim of our study was to show the influence of testosterone replacement therapy on obesity, HbA1c level, hypertension and dyslipidemia in patients with diabetes mellitus and androgen deficiency. Since the FDA warning in 2015, other studies have failed to demonstrate a risk of cardiovascular events in patients on testosterone therapy. Conversely, the Shores, 367 Muraleedharan,233 and Baillargeon373 studies determined that there was no increased risk of MACE in men who were on testosterone therapy. Clinicians should be aware that symptomatic gynecomastia or other breast symptoms are an uncommon side effect in men on testosterone therapy. Hypergonadotropic hypogonadism, which is not a contraindication to begin testosterone therapy, can result from a number of conditions, including congenital abnormalities (KS being the most common), iatrogenic causes (e.g., bilateral orchiectomy, testicular radiation, chemotherapy), testicular trauma, infection, or autoimmune damage. A low or low/normal LH level points to a secondary (central) hypothalamic-pituitary defect, (hypogonadotropic hypogonadism), while an elevated LH level indicates a primary testicular defect (hypergonadotropic hypogonadism).168 In men with hypogonadotropic hypogonadism, the yield from adjunctive tests (e.g., prolactin measurement, pituitary imaging, iron studies) is increased. Screening questionnaires are not an appropriate tool to identify candidates for testosterone therapy. Thus, pituitary dysfunction can develop after radiation therapy for sellar, parasellar, and extrasellar neoplasms (e.g., craniopharyngiomas, meningiomas, germinomas, chordomas, hemangio-pericytomas, pituicytomas, gliomas), head and neck tumors, and following total body irradiation for systemic malignancies. A survey of 120 patients who were treated for infertility at the University of Illinois-Chicago found that the incidence of testosterone deficiency was 45% in men with non-obstructive azoospermia, 42.9% in men with oligospermia, and 16.7% in men with obstructive azoospermia.159 The European Male Aging Study (EMAS)8 studied 3,369 men (mean age 59 years) and culled data on their sexual, physical, and psychological symptoms along with morning total testosterone measurements. Insulin resistance is a common problem in diabetes, and low testosterone can make it worse. This is because fat, especially around the abdomen, is linked to insulin resistance, which makes it harder for the body to use insulin properly. In diabetic men, the symptoms of low testosterone may be more noticeable or confusing because some of the signs of low T are similar to the symptoms of diabetes. Low testosterone, often called "low T," can have various effects on the body. Since having more muscle and less fat can improve insulin sensitivity, this is another way that TRT may help manage diabetes. For men with low T, TRT can help increase energy levels, improve mood, and enhance sexual health. Many studies have looked at whether TRT can also help with blood sugar control. The testosterone therapeutic space is relatively unique. Expert Opinion refers to a statement, achieved by consensus of the Panel, that is based on members' clinical training, experience, knowledge, and judgment for which there is no evidence. A Clinical Principle is a statement about a component of clinical care that is widely agreed upon by urologists or other clinicians for which there may or may not be evidence in the medical literature. Where gaps in the evidence existed, the Panel provides guidance in the form of Clinical Principles or Expert Opinion with consensus achieved using a modified Delphi technique if differences of opinion emerged. Conditional Recommendations also can be supported by any evidence strength. Body of evidence strength Grade C is only rarely used in support of a Strong Recommendation. Moderate Recommendations are directive statements that an action should (benefits outweigh risks/burdens) or should not (risks/burdens outweigh benefits) be undertaken because net benefit or net harm is moderate.
